Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia & Upjohn 2nd quarter consumer health sales up 77% due to Nicorette, Rogaine.

This article was originally published in The Tan Sheet

Executive Summary

PHARMACIA & UPJOHN CONSUMER HEALTHCARE SALES UP 77.4% in the second quarter to $206.8 mil. from $116.6 mil. in the prior-year period "due to the successful introduction of Nicorette gum and the hair regrowth product Rogaine into the U.S. over-the-counter market," the company announced Aug. 5. OTC Nicorette gum is marketed by SmithKline Beecham under a licensing agreement with Pharmacia & Upjohn. Both Rogaine and Nicorette were launched in April
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel